ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
126.526,27
1,51%
S&P 500
5.099,96
1,02%
US Dollar vs BRL
5,1163
0,00%
Bitcoin
63.510,12
0,16%
Brent Oil
88,165
0,00%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Immutep Ltd (IMMP)

  7. Immutep Ltd (IMMP) Notícias

IMMP Immutep Ltd

2,65
0,05 (1,92%)
26 Abr 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Immutep Ltd IMMP NASDAQ Recibo de Depósito
  Variação do Dia (p) Variação do Dia % Último Preço Hora
Upgrade Icon
0,05 1,92% 2,65 17:48:53
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
2,61 2,61 2,70 2,65 2,60
mais cotações »

Notícias Recentes

Data Hora Fonte Título
24/04/202409:00GLOBEImmutep Announces Positive Preliminary Topline Results from..
18/04/202409:00GLOBEImmutep Appoints Leading Research Institute to Conduct..
17/04/202409:00GLOBEImmutep Receives Positive Feedback from the Spanish..
05/03/202410:00GLOBEImmutep Announces First Clinical Data from 90mg Dosing of..
30/01/202410:00GLOBEImmutep Quarterly Activities Report Q2 FY24
04/01/202410:00GLOBEFirst Patient Dosed in Trial Evaluating Efti and the..
21/12/202310:00GLOBEImmutep Receives Constructive Regulatory Feedback on..
07/12/202310:00GLOBEImmutep Receives A$2.6 million R&D Tax Incentive from French..
22/11/202310:00GLOBEImmutep Announces Site Expansion for INSIGHT-003 Phase I..
09/11/202310:00GLOBEImmutep Completes Enrollment in TACTI-003 Phase IIb Trial of..
06/11/202310:00GLOBEImmutep Announces Completion of the Safety Lead-In and..
03/11/202313:00GLOBEImmutep Announces New Biomarker Data from TACTI-002 Phase II..
02/11/202309:00GLOBEImmutep to Participate in November Investor Events
31/10/202309:00GLOBEImmutep Quarterly Activities Report Q1 FY24
25/10/202309:00GLOBEImmutep receives ~A$1.13 million R&D Tax Incentive
24/10/202309:00GLOBEImmutep Reports Promising Clinical Data from INSIGHT-003..
23/10/202309:00GLOBEImmutep’s Efti in Combination with KEYTRUDA® Generates..
16/10/202309:00GLOBEImmutep Announces Publication of Abstracts at ESMO Congress..
03/10/202309:00GLOBEImmutep Announces Abstract Accepted for Presentation at the..
21/09/202309:00GLOBECommercial Manufacturing of Eftilagimod Alpha at 2000L Scale..
05/09/202310:00GLOBEImmutep to Participate in September Investor Conferences
01/08/202309:00GLOBEImmutep Receives Positive Scientific Advice from European..
31/07/202309:00GLOBEImmutep to Present Overall Survival Data in 1st Line..
28/07/202309:00GLOBEFirst Patient Dosed in Chemotherapy-Free Triple Combination..
27/06/202309:00GLOBEImmutep Completes A$80 Million Capital Raise
20/06/202309:00GLOBEImmutep Granted United States Patent for IMP761, a..
07/06/202309:00GLOBEImmutep to Participate at the Jefferies Healthcare..
05/06/202309:00GLOBEImmutep Reports Final Positive Data in 2nd Line Head and..
02/06/202309:00GLOBEImmutep Successfully Completes Institutional Placement and..
29/05/202309:00GLOBEImmutep Selects Charles River Laboratories for IMP761’s GLP..
26/05/202309:00GLOBEImmutep Announces Publication of Abstracts for ASCO 2023..
25/05/202309:00GLOBEImmutep Doses First Patient in AIPAC-003 Phase II/III Trial..
24/05/202309:00GLOBEImmutep Announces Promising New Clinical Data from Triple..
17/05/202309:00GLOBEImmutep’s Efti in Combination with Pembrolizumab Achieves..
16/05/202309:00GLOBEImmutep Receives Positive Feedback from FDA on Late-Stage..
09/05/202309:00GLOBEImmutep to Participate in the JMP Securities Life Sciences..
02/05/202309:00GLOBEImmutep Announces KOL Event Focused on Eftilagimod Alpha in..
01/05/202309:00GLOBEImmutep Receives Approval to Initiate INSIGHT-005 Trial..

Seu Histórico Recente

NASDAQ
IMMP
Immutep
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados